HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dep predicting 7% sales decline in the second quarter due to Agree and Halsa.

This article was originally published in The Rose Sheet

Executive Summary

DEP PREDICTING 7% SALES DECLINE IN THE SECOND QUARTER (ended Jan. 31) to approximately $31 mil., and a net loss of between 10 [cents] and 15 [cents] per share, the Los Angeles-based company announced Feb. 8. In the year-earlier quarter, Dep recorded a net loss of 70 [cents] a share. The firm continues to attribute its losses to the Agree and Halsa hair care brands, acquired from S.C. Johnson in 1993 ("The Rose Sheet" July 19, 1993, p. 10). Dep filed suit against S.C. Johnson in March for allegedly damaging the brands' North American market before selling them to Dep ("The Rose Sheet" March 14, p. 4). The trial date has been set for Sept. 12.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001307

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel